Evidence map›Paper›PMID 41070346›Full record

ReviewFrontiers in cell and developmental biology2025

Fueling the fire-a pan-cancer analysis of MYC-regulated lipid metabolism.

Tilottama Chatterjee, Ethan Beffert, Daniel Liefwalker

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tilottama ChatterjeeDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, OR, United States.
Ethan BeffertDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, OR, United States.
Daniel LiefwalkerDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, OR, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oncogene MYC and its product c-Myc are responsible for a multitude of changes in cancerous cells that trigger cell growth, proliferation and metastasis. The efforts to understand the multifaceted role of MYC in malignancies have highlighted metabolic reprogramming as a prominent function of this transcription factor, with effects across glycolysis, protein and lipid metabolism, mitochondrial respiration and energy storage. In particular, the role of MYC in lipid metabolism has been the focus of several studies in the past two decades, elucidating how the balance of lipid production and breakdown aids in tumor proliferation. Here, we provide a comprehensive summary of how modulation of MYC alters fatty acid synthesis and degradation, the metabolism of compound lipids, and the consequences for other metabolic pathways. The observed effects are highly cell type-specific, highlighting the MYC network's ability to harness the existing cellular signaling pathways and specific tumor microenvironment to promote tumor growth and metastasis.

Indexed as

fatty acid synthesislipidslipid synthesismetabolic reprogrammingmetabolismMYC

Identifiers

PMID41070346
PMCPMC12504247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.